Default Category
-
Target: Responding to the Recession
Gulati, Ranjay; Lal, Rajiv; Ross, CatherineCase HBS-510016-EMarketingWithin 10 months of Gregg Steinhafel's taking over as CEO at Target, the U.S. was mired in the most significant economic downturn in 50 years. Top competitor Wal-Mart had positioned itself well for the crisis, while Target's same store sales began to slide. While Steinhafel believed that Target's long-term strategy and positioning were right, he pondered a set of strategic and operational challenges. Did Target have the right mix of offensive and...Starting at €8.20
-
Paydiant
Alvarez, Jose B.; Williamson, Elizabeth C.; Weber, JamesCase HBS-511065-EMarketingTo maximize their effectiveness, color cases should be printed in color. Kevin Laracey, founder of Paydiant, needed to figure out how to launch a payment processing company with a new technology based on smart phones. Consumers had increasingly turned to electronic payment methods such as credit cards and debit cards to make purchases. Retailers, however, felt that major credit and debit card issuers had too much market power which was leading to...Starting at €8.20
-
Pfizer and AstraZeneca: Marketing an Acquisition (B)
Quelch, John A.; Weber, JamesCase HBS-515008-EMarketingThis (B) case provides a brief description of the outcome of the (A) case.Starting at €5.74
-
Target: Responding to the Recession (Spanish Version)
Gulati, Ranjay; Lal, Rajiv; Ross, CatherineCase HBS-515S02MarketingDentro de los 10 meses de Gregg Steinhafel de tomar el cargo de CEO en Target, los EE.UU. estaba sumida en la recesión económica más importante en 50 años. Principal competidor de Wal-Mart había posicionado bien para la crisis, mientras que las ventas mismas tiendas de Target comenzó a deslizarse. Mientras Steinhafel cree que la estrategia y posicionamiento a largo plazo de Target tenían razón, reflexionó un conjunto de retos estratégicos y opera...Starting at €8.20
-
Pfizer and AstraZeneca: Marketing an Acquisition (A)
Quelch, John A.; Weber, JamesCase HBS-515007-EMarketingIn 2014, Pfizer proposed a friendly acquisition of AstraZeneca, but the AstraZeneca board resisted over price and strategy concerns. Was this good for pharmaceutical consumers? Pfizer, like pharmaceutical companies in general, faced difficulties in growing sales due to the challenges of developing new drugs. Over the previous decade or more, Pfizer had pursued acquisitions as a way to acquire new drugs, increase sales, and to reduce costs by comb...Starting at €8.20